Trius Therapeutics, Inc. (TSRX) Earnings
|
Expand Research on TSRX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +37.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/6/13 | Q212 | -$0.41 | -$0.33 | -$0.08 | $1.3M | $3.71M | N/A |  | | Details | |
| 5/8/12 | Q112 | -$0.22 | -$0.34 | +$0.12 | $9.83M | $5.38M | N/A | | | Details | |
| 3/13/12 | Q411 | -$0.44 | -$0.49 | +$0.05 | $3.52M | $3.82M | N/A | | | Details | |
3/23/11  |
 |
Q410 | -$0.37 | -$0.42 | +$0.05 | $2.52M | $1.85M | N/A | | | Details |
